vs

Side-by-side financial comparison of ALASKA AIR GROUP, INC. (ALK) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $3.3B, roughly 1.7× ALASKA AIR GROUP, INC.). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs -5.8%, a 17.5% gap on every dollar of revenue. On growth, TENET HEALTHCARE CORP posted the faster year-over-year revenue change (9.0% vs 5.2%). Over the past eight quarters, ALASKA AIR GROUP, INC.'s revenue compounded faster (6.7% CAGR vs 1.5%).

Alaska Air Group, Inc. is an American airline holding company based in SeaTac, Washington, United States. The group owns two mainline carriers, Alaska Airlines and Hawaiian Airlines, along with a regional airline, Horizon Air. Alaska Airlines in turn wholly owns an aircraft ground handling company, McGee Air Services.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

ALK vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.7× larger
THC
$5.5B
$3.3B
ALK
Growing faster (revenue YoY)
THC
THC
+3.8% gap
THC
9.0%
5.2%
ALK
Higher net margin
THC
THC
17.5% more per $
THC
11.7%
-5.8%
ALK
Faster 2-yr revenue CAGR
ALK
ALK
Annualised
ALK
6.7%
1.5%
THC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALK
ALK
THC
THC
Revenue
$3.3B
$5.5B
Net Profit
$-193.0M
$644.0M
Gross Margin
Operating Margin
-8.5%
15.4%
Net Margin
-5.8%
11.7%
Revenue YoY
5.2%
9.0%
Net Profit YoY
12.6%
EPS (diluted)
$-1.69
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALK
ALK
THC
THC
Q1 26
$3.3B
Q4 25
$3.6B
$5.5B
Q3 25
$3.8B
$5.3B
Q2 25
$3.7B
$5.3B
Q1 25
$3.1B
$5.2B
Q4 24
$3.5B
$5.1B
Q3 24
$3.1B
$5.1B
Q2 24
$2.9B
$5.1B
Net Profit
ALK
ALK
THC
THC
Q1 26
$-193.0M
Q4 25
$21.0M
$644.0M
Q3 25
$73.0M
$579.0M
Q2 25
$172.0M
$522.0M
Q1 25
$-166.0M
$622.0M
Q4 24
$71.0M
$572.0M
Q3 24
$236.0M
$681.0M
Q2 24
$220.0M
$477.0M
Operating Margin
ALK
ALK
THC
THC
Q1 26
-8.5%
Q4 25
2.1%
15.4%
Q3 25
3.9%
16.8%
Q2 25
7.5%
15.6%
Q1 25
-6.3%
18.1%
Q4 24
2.1%
16.2%
Q3 24
11.1%
21.3%
Q2 24
11.1%
14.9%
Net Margin
ALK
ALK
THC
THC
Q1 26
-5.8%
Q4 25
0.6%
11.7%
Q3 25
1.9%
10.9%
Q2 25
4.6%
9.9%
Q1 25
-5.3%
11.9%
Q4 24
2.0%
11.3%
Q3 24
7.7%
13.3%
Q2 24
7.6%
9.3%
EPS (diluted)
ALK
ALK
THC
THC
Q1 26
$-1.69
Q4 25
$0.14
$4.22
Q3 25
$0.62
$3.86
Q2 25
$1.42
$3.14
Q1 25
$-1.35
$4.27
Q4 24
$0.58
$3.79
Q3 24
$1.84
$4.89
Q2 24
$1.71
$2.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALK
ALK
THC
THC
Cash + ST InvestmentsLiquidity on hand
$451.0M
$2.9B
Total DebtLower is stronger
$5.3B
$13.1B
Stockholders' EquityBook value
$3.7B
$4.2B
Total Assets
$20.3B
$29.7B
Debt / EquityLower = less leverage
1.43×
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALK
ALK
THC
THC
Q1 26
$451.0M
Q4 25
$627.0M
$2.9B
Q3 25
$2.3B
$3.0B
Q2 25
$2.1B
$2.6B
Q1 25
$2.5B
$3.0B
Q4 24
$2.5B
$3.0B
Q3 24
$2.5B
$4.1B
Q2 24
$2.5B
$2.9B
Total Debt
ALK
ALK
THC
THC
Q1 26
$5.3B
Q4 25
$4.8B
$13.1B
Q3 25
$5.0B
$13.1B
Q2 25
$4.9B
$13.1B
Q1 25
$4.8B
$13.1B
Q4 24
$4.5B
$13.1B
Q3 24
$4.6B
$12.8B
Q2 24
$2.7B
$12.8B
Stockholders' Equity
ALK
ALK
THC
THC
Q1 26
$3.7B
Q4 25
$4.1B
$4.2B
Q3 25
$4.0B
$4.0B
Q2 25
$3.9B
$3.7B
Q1 25
$4.1B
$4.2B
Q4 24
$4.4B
$4.2B
Q3 24
$4.5B
$3.8B
Q2 24
$4.2B
$3.5B
Total Assets
ALK
ALK
THC
THC
Q1 26
$20.3B
Q4 25
$20.4B
$29.7B
Q3 25
$20.0B
$29.4B
Q2 25
$19.9B
$28.7B
Q1 25
$19.8B
$29.2B
Q4 24
$19.8B
$28.9B
Q3 24
$19.6B
$29.4B
Q2 24
$15.3B
$29.3B
Debt / Equity
ALK
ALK
THC
THC
Q1 26
1.43×
Q4 25
1.17×
3.10×
Q3 25
1.24×
3.26×
Q2 25
1.26×
3.49×
Q1 25
1.16×
3.13×
Q4 24
1.04×
3.14×
Q3 24
1.03×
3.33×
Q2 24
0.63×
3.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALK
ALK
THC
THC
Operating Cash FlowLast quarter
$229.0M
$731.0M
Free Cash FlowOCF − Capex
$367.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
10.2%
6.6%
Cash ConversionOCF / Net Profit
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALK
ALK
THC
THC
Q1 26
$229.0M
Q4 25
$185.0M
$731.0M
Q3 25
$229.0M
$1.1B
Q2 25
$376.0M
$936.0M
Q1 25
$459.0M
$815.0M
Q4 24
$274.0M
$-331.0M
Q3 24
$318.0M
$1.0B
Q2 24
$580.0M
$747.0M
Free Cash Flow
ALK
ALK
THC
THC
Q1 26
Q4 25
$367.0M
Q3 25
$778.0M
Q2 25
$743.0M
Q1 25
$642.0M
Q4 24
$-661.0M
Q3 24
$829.0M
Q2 24
$602.0M
FCF Margin
ALK
ALK
THC
THC
Q1 26
Q4 25
6.6%
Q3 25
14.7%
Q2 25
14.1%
Q1 25
12.3%
Q4 24
-13.0%
Q3 24
16.2%
Q2 24
11.8%
Capex Intensity
ALK
ALK
THC
THC
Q1 26
10.2%
Q4 25
6.6%
Q3 25
5.3%
Q2 25
3.7%
Q1 25
3.3%
Q4 24
6.5%
Q3 24
4.2%
Q2 24
2.8%
Cash Conversion
ALK
ALK
THC
THC
Q1 26
Q4 25
8.81×
1.14×
Q3 25
3.14×
1.83×
Q2 25
2.19×
1.79×
Q1 25
1.31×
Q4 24
3.86×
-0.58×
Q3 24
1.35×
1.53×
Q2 24
2.64×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALK
ALK

Passenger revenue$2.9B88%
Loyalty program other revenue$227.0M7%
Cargo and other revenue$153.0M5%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons